Filter
857
Text search:
pharmaceutical
manufacturers
Featured
Recommendations
89
New Publications
197
Language
Document type
No document type
361
Studies & Reports
194
Guidelines
161
Manuals
63
Strategic & Response Plan
44
Fact sheets
13
Training Material
8
Situation Updates
7
Resource Platforms
3
Brochures
2
Infographics
1
Countries / Regions
Global
43
India
28
Kenya
27
Nigeria
23
Western and Central Europe
22
Ethiopia
19
South Africa
15
Uganda
11
Ukraine
11
Sierra Leone
10
Tanzania
10
Eastern Europe
10
Ghana
9
Philippines
9
Rwanda
9
Namibia
9
Latin America and the Carribbean
9
Zimbabwe
8
Malawi
8
Nepal
7
Africa
7
Liberia
6
Bangladesh
6
Eastern Europe and Central Asia
6
Zambia
5
Indonesia
5
Myanmar / Burma
5
South–East Asia Region
5
Senegal
4
Syria
4
Cambodia
4
Thailand
4
Botswana
4
West and Central Africa
4
Burkina Faso
3
Haiti
3
East and Southern Africa
3
Asia
3
Egypt
2
Sudan
2
Eswatini/ Swaziland
2
North Macedonia
2
Serbia
2
Middle East and North Africa
2
Western Pacific Region
2
Albania
2
Laos
2
Russia
2
Kyrgyzstan
2
Vietnam
2
North America
2
Jamaica
2
Congo, Democratic Republic of
1
Mali
1
USA
1
Cameroon
1
Somalia
1
Pakistan
1
South Sudan
1
Afghanistan
1
Germany
1
China
1
Mozambique
1
Papua New Guinea
1
Benin
1
Lesotho
1
Chile
1
Armenia
1
Mongolia
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Moldova
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Georgia
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
264
Clinical Guidelines
88
Public Health
44
Key Resources
40
Pharmacy & Technologies
36
Women & Child Health
29
Capacity Building
7
Toolboxes
Pharmacy
114
AMR
105
COVID-19
61
TB
45
HIV
44
Mental Health
32
Rapid Response
29
NTDs
28
NCDs
19
Global Health Education
18
Planetary Health
18
Conflict
15
Malaria
14
2.0 Rapid Response
14
Caregiver
13
Health Financing Toolbox
12
Specific Hazards
7
Disability
6
Ebola & Marburg
5
Polio
5
Refugee
5
Zika
2
Cholera
1
Natural Hazards
1
Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended
This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19.
In this edition, new information includes updated mask re
...
This joint ECDC-European Union Aviation Safety Agency (EASA) document aims to support Member States in determining a coordinated approach to reduce the risks related to the movement of people by air within and between the EU/EEA countries and the UK in the context of the COVID-19 pandemic, noting th
...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac
...
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available at all times in adequate amounts”. However, there
...
Guidelines for Medicine Donations
recommended
This 3rd edition of Guidelines for medicine donations has been developed by the World Health Organization (WHO) in cooperation with major international agencies active in humanitarian relief and development assistance. The guidelines are intended to improve the quality of medicine donations in inter
...
WHO Technical Report Series, No. 908, 2003, Annex 9. This guide is intended for those involved in the storage, transportation and distribution of pharmaceuticals. It describes the special measures considered appropriate for the storage and transportation of pharmaceuticals.
WHO Model Formulary
recommended
For each medicine the Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine for a range of conditions
Prices people pay for medicines.
Antimicrobial resistance (AMR) as a serious public health threat was globally acknowledged by WHO in 2015, through the launch of the Global Action Plan (GAP). With a limited number of new antibiotics in the developmental pipeline, many countries are in the process of establishing strategies for anti
...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn
...